The Navigator Company SA (NVG)
Euronext Lisbon · Portugal · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 3.036 |
|---|---|
| 52-week range | 2.888 – 3.590 |
| Return, 1 month / 3 months | −6.8% / −5.4% |
| Return, 1 year / 3 years | +1.0% / +0.4% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 16.3% |
| Worst drawdown (1 year) | -11.7% |
| Average daily value traded | 1.97M EUR |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Navigator Company is a Portuguese producer of pulp and paper, based in Portugal and drawing on eucalyptus forests it manages. It makes bleached eucalyptus pulp and uncoated woodfree paper used for printing and writing, along with tissue products for household and professional use. Its customers are paper converters, printers, publishers and tissue buyers in Europe and other export markets, and it also supplies biomass-based energy from its industrial operations.
On this site The Navigator Company SA appears as a stock on the Euronext Lisbon (Portugal), code NVG, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Navigator Company SA (NVG) trades on the Euronext Lisbon in Portugal. It last closed at EUR 3.036 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 13 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.0% and over the last three months it fell 5.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -14.6% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.4% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | 8.4% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.7% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.97M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −6.8% |
| 3 months | −5.4% |
| 6 months | −6.9% |
| 1 year | +1.0% |
| 3 years | +0.4% |
| 5 years | +36.7% |
Signals
| 50-day / 200-day average | 3.194 / 3.224 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.044 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 0.1125 |
| 27 Jun 2025 | EUR 0.1055 |
| 10 Jan 2025 | EUR 0.1406 |
| 7 Jun 2024 | EUR 0.2109 |
| 29 May 2023 | EUR 0.2812 |
| 8 Dec 2022 | EUR 0.2109 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.